-
EP0515228
European procedure
Extract from the Register of European Patents
EP About this file: EP0515228
| EP0515228 - Essentially pure human parathyroid hormone [Right-click to bookmark this link] | |||
| Former [1992/48] | Essential pure human parathyroid hormone | ||
| [1998/13] | Status | No opposition filed within time limit Status updated on 29.01.1999 Database last updated on 16.07.2024 | Most recent event Tooltip | 29.01.1999 | No opposition filed within time limit | published on 17.03.1999 [1999/11] | Applicant(s) | For all designated states Astra Aktiebolag 151 85 Södertälje / SE | [1997/38] |
| Former [1997/28] | For all designated states Astra Aktiebolag 151 85 Södertälje / SE | ||
| For all designated states GLAXO CANADA INC. 7333 Mississauga Road North Mississauga, Ontario L5N 6L4 / CA | |||
| Former [1992/48] | For all designated states Allelix Biopharmaceuticals Inc. 6850 Goreway Drive Mississauga Ontario, L4V 1P1 / CA | ||
| For all designated states GLAXO CANADA INC. 7333 Mississauga Road North Mississauga, Ontario L5N 6L4 / CA | Inventor(s) | 01 /
Sindrey, Dennis R. 24 Mabelle Avenue, Apt. 3415 Etobicoke, Ontario M9A 4X8 / CA | [1992/48] | Representative(s) | Höglund, Lars, et al Astra AB Patent Department S-151 85 Södertälje / SE | [N/P] |
| Former [1998/03] | Höglund, Lars, et al Astra AB Patent Department S-151 85 Södertälje / SE | ||
| Former [1997/38] | Mercer, Christopher Paul, et al Carpmaels & Ransford 43, Bloomsbury Square London WC1A 2RA / GB | ||
| Former [1997/28] | (deleted) | ||
| Former [1992/48] | Mercer, Christopher Paul Carpmaels & Ransford 43, Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 92304692.4 | 22.05.1992 | [1992/48] | Priority number, date | US19910707114 | 23.05.1991 Original published format: US 707114 | [1992/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0515228 | Date: | 25.11.1992 | Language: | EN | [1992/48] | Type: | A3 Search report | No.: | EP0515228 | Date: | 04.05.1994 | Language: | EN | [1994/18] | Type: | B1 Patent specification | No.: | EP0515228 | Date: | 25.03.1998 | Language: | EN | [1998/13] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 14.03.1994 | Classification | IPC: | C12N15/16, C12P21/02, C07K14/635, C07K1/20, A61K38/29 | [1998/13] | CPC: |
C07K14/635 (EP,US);
A61P19/10 (EP);
A61P3/00 (EP);
A61P43/00 (EP);
A61K38/00 (EP,US);
Y02A50/30 (EP,US)
|
| Former IPC [1992/48] | C12N15/16, C12P21/02, C07K13/00, C07K3/20, A61K37/24 | Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, MC, NL, PT, SE [1992/48] | Title | German: | Essentiell reines menschliches Parathyroidhormon | [1998/13] | English: | Essentially pure human parathyroid hormone | [1998/13] | French: | Hormone parathyroidienne humaine essentiellement pure | [1998/13] |
| Former [1992/48] | Reines, essentielles menschliches Parathyroidhormon | ||
| Former [1992/48] | Essential pure human parathyroid hormone | ||
| Former [1992/48] | Hormone parathyroidienne humaine essentielle pure | Examination procedure | 19.10.1994 | Examination requested [1994/50] | 19.02.1996 | Despatch of a communication from the examining division (Time limit: M04) | 20.06.1996 | Reply to a communication from the examining division | 26.02.1997 | Despatch of communication of intention to grant (Approval: No) | 16.08.1997 | Fee for grant paid | 16.08.1997 | Fee for publishing/printing paid | 08.09.1997 | Despatch of communication of intention to grant (Approval: later approval) | 29.09.1997 | Communication of intention to grant the patent | Opposition(s) | 29.12.1998 | No opposition filed within time limit [1999/11] | Fees paid | Renewal fee | 02.05.1994 | Renewal fee patent year 03 | 11.05.1995 | Renewal fee patent year 04 | 06.05.1996 | Renewal fee patent year 05 | 07.05.1997 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [DA]EP0357391 (ALLELIX INC [CA]); | [X]WO9105050 (CANADA MAJESTY IN RIGHT OF [CA]) [X] 1,2,19 * page 31, line 35 - page 32, line 17; figures 12,13; examples 12,13 * | [DY] - S.A. RABBANI ET AL, "Recombinant human parathyroid hormone synthesized in E.coli", JOURNAL OF BIOLOGICAL CHEMISTRY, BALTIMORE, MD US, (19880125), vol. 263, no. 3, pages 1307 - 1313 [DY] 1,2,8-19 * whole document especially page 1308 right column to page 1309 left column * | [Y] - M.T.W. HEARN, "reversed-phase high performance liquid chromatography", METHODS IN ENZYMOLOGY, ACADEMIC PRESS , INC., (1984), vol. 104, pages 190 - 212 [Y] 1,2,8-19 * page 204 - page 205; table I * | [Y] - P. M. YOUNG ET AL, "Optimization of high-performance liquid chromatographic peptide separations with alternative mobile and stationary phases", JOURNAL OF CHROMATOGRAPHY, AMSTERDAM NL, (1990), vol. 512, pages 273 - 281 [Y] 1,2,8-19 * page 273 - page 274; figure 4 * | [Y] - U. JUERGENS, "Alkylamine / phosphoric acid as a universal buffer system for basic and acidic mobile phases in HPLC", JOURNAL OF LIQUID CHROMATOGRAPHY, (1988), vol. 11, no. 9&10, pages 1925 - 1940 [Y] 1,2,8-19 *conclusions *; page 1938 - page 1939 * | [DA] - TERUTOSHI KIMURA ET AL, "Solution synthesis of (ASN76)-human parathyroid hormone(1-84)", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, DULUTH, MINNESOTA US, (19830729), vol. 114, no. 2, pages 493 - 499 |